Granulomatous lung disease in lymphoma patient after rituximab treatment Source: Virtual Congress 2020 – Interstitial lung diseases Year: 2020
Pulmonary involvement in behcet's disease Source: Eur Respir J 2002; 20: Suppl. 38, 63s Year: 2002
Efficiency of standard chemotherapy of patients with pulmonary TB with relapses and treatment failure at drug resistance of M. tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 339s Year: 2001
Efficacy of standard chemotherapy regimen in patients with newly detected sputum-positive destructive pulmonary tuberculosis Source: Eur Respir J 2003; 22: Suppl. 45, 40s Year: 2003
Pulmonary tuberculosis masquerading as metastatic lung disease Source: Eur Respir Rev 2015; 25: 97-98 Year: 2016
Effectiveness of chemotherapy in newly detected patients with pulmonary tuberculosis with poly-resistance Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010
Development of mycobacterium tuberculosis additional drug resistance during chemotherapy of disseminated pulmonary tuberculosis Source: Eur Respir J 2007; 30: Suppl. 51, 663s Year: 2007
Clinical and radiological correlation of pulmonary complications in CHOP versus rituximab-CHOP regimen treated non-Hodgkin’s lymphoma in Thailand Source: International Congress 2017 – Rare diseases Year: 2017
Miliary tuberculosis in patient with Crohn‘s disease Source: Eur Respir J 2006; 28: Suppl. 50, 27s Year: 2006
Diffusion lung capacity changes in Hodgkin lymphoma patients before and after ABVD chemotherapy Source: International Congress 2015 – Lung function: exploring the boundaries of the respiratory system Year: 2015
Tolerance and hepatotoxicity of different versions of polychemotherapy in patients with destructive pulmonary tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 467s Year: 2001
Pulmonary hydatid disease: a unique treatment for an uncommon disease Source: Eur Respir J 2007; 30: Suppl. 51, 392s Year: 2007
Efficacy of a standard chemotherapy regimen in the management of sputum-positive pulmonary TB relapses Source: Eur Respir J 2003; 22: Suppl. 45, 41s Year: 2003
Evaluation of tuberculosis risk in patients submitted to chronic immunosuppressive therapy for osteoarticular immune disease Source: Eur Respir J 2006; 28: Suppl. 50, 131s Year: 2006
Treatment of relapsed hydatid disease of lungs. Source: Virtual Congress 2020 – Thoracic surgery: lung cancer and infectious disease Year: 2020
Infliximab: An effective rescue therapy in refractory extra-pulmonary sarcoidosis Source: Annual Congress 2013 –Sarcoidosis and other granulomatosis Year: 2013
Dynamics of γ-interferon in pulmonary tuberculosis in children - in the course of chemotherapy using isofon Source: Eur Respir J 2005; 26: Suppl. 49, 655s Year: 2005
Pulmonary function changes after chemotherapy and radiotherapy for Lymphoma. Source: International Congress 2017 – Case reports and series Year: 2017
Extrapulmonary tuberculosis in patients with chronic kidney disease receiving renal replacement therapy Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019
Primary pulmonary non-Hodgkin's lymphoma [NHL] and advanced NHL with pulmonary involvement -rare entity and difficult diagnosis Source: Eur Respir J 2002; 20: Suppl. 38, 467s Year: 2002